BI-4020

Catalog No.S8921

For research use only.

BI-4020 is an orally active, non-covalent EGFR inhibitor with IC50 of 0.6 nM and 0.2 nM for EGFRdel19 T790M C797S as biomarker potency and anti-proliferation potency in BaF3 cells, respectively.

BI-4020 Chemical Structure

CAS No. 2664214-60-0

Purity & Quality Control

Choose Selective EGFR Inhibitors

Other EGFR Products

Biological Activity

Description BI-4020 is an orally active, non-covalent EGFR inhibitor with IC50 of 0.6 nM and 0.2 nM for EGFRdel19 T790M C797S as biomarker potency and anti-proliferation potency in BaF3 cells, respectively.
Targets
EGFRdel19 T790M C797S [1]
(anti-proliferation potency)
EGFRdel19 T790M C797S [1]
(biomarker potency)
0.2 nM 0.6 nM
In vitro

BI-4020 is a noncovalent, macrocyclic TKI, which inhibits not only the triple mutant EGFRdel19 T790M C797S variant but also the double mutant EGFRdel19 T790M and primary mutant EGFRdel19 while sparing activity against EGFRwt.[1]

In vivo

BI-4020 shows high potency on EGFR mutant cells, high kinome selectivity, and good DMPK properties, which leads to tumor regressions in the human PC-9 (EGFRdel19 T790M C797S) triple mutant NSCLC xenograft model in mice.[1]

Protocol (from reference)

Cell Research:

[1]

  • Cell lines: BaF3 cells
  • Concentrations: --
  • Incubation Time: 4 h, 3 days
  • Method:

    Kinase selectivity is determined using the SelectScreen Kinase Profiling Services. The inhibition of the p-EGFRdel19 T790M C797S signal in BaF3 cells is measured after 4 h BI-4020 treatment. BaF3 cells bearing EGFRdel19 T790M C797S protein are treated for 3 days with BI-4020, and the effect on proliferation is measured.

Animal Research:

[1]

  • Animal Models: NMRI mice
  • Dosages: 10 mg/kg; 1 mg/kg
  • Administration: Oral gavage; IV

Solubility (25°C)

In vitro

Chemical Information

Molecular Weight 542.68
Formula

C30H38N8O2

CAS No. 2664214-60-0
Storage 3 years -20°C powder
2 years -80°C in solvent

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy BI-4020 | BI-4020 supplier | purchase BI-4020 | BI-4020 cost | BI-4020 manufacturer | order BI-4020 | BI-4020 distributor